SRK 439
Alternative Names: SRK-439Latest Information Update: 22 Nov 2024
Price :
$50 *
At a glance
- Originator Scholar Rock
- Class Monoclonal antibodies; Obesity therapies
- Mechanism of Action Myostatin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Obesity
Highest Development Phases
- Preclinical Obesity